[Rosuvastatin in prevention of cardiac complications following surgical treatment of patients with vascular pathology].
Angiol Sosud Khir
; 15(3): 9-13, 2009.
Article
en Ru
| MEDLINE
| ID: mdl-20092176
ABSTRACT
The article deals with the findings of studying the use of rosuvastatin in patients after endured reconstructive operations on the brachiocephalic arteries and aortofemoral segment in order to prevent cardiac atherothrombotic complications. A total of thirty patients were given "Crestors" at a daily dose of 10 mg for two weeks prior to surgery and for two weeks postoperatively and were found to have a significant decrease in the average levels of total cholesterol and low-density lipoproteins, which was accompanied and followed by certain improvement in the functional state of the vascular wall, with no cardiac complications being observed in either case.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
2_ODS3
Problema de salud:
2_muertes_prematuras_enfermedades_notrasmisibles
Asunto principal:
Pirimidinas
/
Sulfonamidas
/
Procedimientos Quirúrgicos Vasculares
/
Embolia por Colesterol
/
Inhibidores de Hidroximetilglutaril-CoA Reductasas
/
Aterosclerosis
/
Fluorobencenos
Tipo de estudio:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Ru
Revista:
Angiol Sosud Khir
Asunto de la revista:
CARDIOLOGIA
Año:
2009
Tipo del documento:
Article